Aims/hypothesis. There is an emerging epidemic of Type II (non-insulin-dependent) diabetes mellitus of youth in Japan and in many other developed countries. The aim of this study was to determine the prevalence of mutations in the hepatocyte nuclear factor (HNF)-1α gene (TCF1) in a large group of Japanese patients with early-onset non-Type I (insulin-dependent) diabetes mellitus. Since approximately 20% of Caucasian patients with HNF-1α mutations have been shown to be obese or overweight, we also examined the association of genetic variations in TCF1 with body weight in Japanese subjects. Methods. We examined 203 patients with non-Type 1 diabetes who had been diagnosed before they reached 15 years of age. Ten exons and flanking introns of TCF1 of these patients were directly sequenced for mutations. Results. We found 14 different mutations in 18 patients (8.9%), including one that was found to be de novo. The patients with the mutations had lower BMI (20.1±3.0 kg/m 2 ) at diagnosis than the patients without them (24.5±6.0 kg/m 2 ) (p=0.0024). All of the patients with the mutations, except for one, Y120, had normal body weight (BMI<25 kg/m 2 ); the frequency of HNF-1α mutations in the non-obese patients of this study was 17% (17/101). Patient Y120, who had atypical symptoms of mild obesity and insulin resistance at diagnosis, was found to have inherited an additional mutation in an obesity-related gene. Type II diabetes in Caucasians. In contrast, Type II diabetes in Japanese subjects is characterized primarily by pancreatic beta-cell dysfunction, possibly reflecting genetic heterogeneity in the pathogenesis of diabetes between the two populations.
Type II diabetes in Caucasians. In contrast, Type II diabetes in Japanese subjects is characterized primarily by pancreatic beta-cell dysfunction, possibly reflecting genetic heterogeneity in the pathogenesis of diabetes between the two populations.
Maturity-onset diabetes of the young is an autosomal dominant form of early-onset diabetes. Because MODY is characterized primarily by insulin-secretion defects rather than by impaired insulin action, this form of diabetes could well be a suitable model for examining the pathophysiology of Type II diabetes in Japanese subjects. Six forms of MODY have been identified to date. The third form, MODY3 [1] , which is caused by mutations in the hepatocyte nuclear factor (HNF)-1α gene (TCF1), seems to be the most The recent increase in the incidence of Type II (noninsulin-dependent) diabetes mellitus of youth in Japan and in many other developed countries is a result of the interaction of many genetic and non-genetic factors. Obesity and insulin resistance are associated with common MODY identified in Japanese subjects so far. Despite the single gene defects, MODY3 often presents with differing severity even in the same family [2] . The wide range of phenotypes of the disease suggests the presence of modifying factors in the genetic background.
It has been shown previously that approximately 20% of Caucasian subjects with HNF-1α mutations are obese or overweight [3] , although obesity is on average not a characteristic feature of this form of diabetes. Our preliminary study suggested that MODY3 could be common in young Japanese non-obese patients [4] , but the occurrence of obesity was not investigated. In the present study, we estimated the prevalence of HNF-1α mutations in early-onset non-Type 1 diabetes in a large group of young Japanese patients and also investigated the association of HNF-1α mutations with body weight.
Subjects and methods
We examined 203 patients with non-Type 1 diabetes whose glycosuria was first noticed by annual school health examination before 15 years of age. The patients were recruited at random from several clinics on the single criterion of the age of diagnosis, without regard to family history of diabetes. Personal data on the patients, such as sex, family history, body weight, and current therapy, were then obtained by questionnaire or from medical records. Of these patients (male/female 79/124; BMI 23.7±6.0 kg/m 2 ), 81 were being treated with insulin or hypoglycaemic agents, and the remainder with diet alone. Diabetic complications of nephropathy and retinopathy were found in four and four patients, respectively. A body mass index greater than 25 kg/m 2 is the cut-off for obesity in this study, according to the criteria of the Japan Society for the Study of Obesity. The ten exons and flanking introns of TCF1 of all of the patients were screened for mutations by direct DNA sequencing of the polymerase chain reaction products, as described previously [4] . All subjects gave their informed consent and the research protocol was approved by the Ethics Committee of the Gunma University.
Clinical data are expressed as means ± SD. Comparison of variables between groups was carried out using the two-tailed Student's t test and/or the Mann-Whitney non-parametric test. Statistical analysis was done using StatView 5.0 software (SAS Institute, Cary, N.C., USA)
Results

Identification of HNF-1α mutations in early-onset
Type II diabetes. Screening the 203 patients resulted in the identification of 14 different mutations in 18 patients (8.9%) (Fig. 1 ). These include eleven missense mutations R131W, R159Q, R200Q, R203H, V233L, A239V, R271G, R271Q, R271W, R272H, and V567I, two frameshift mutations P291fsinsC and P379fsdelC, and one nonsense mutation R229X. Of these, the mutations V233L, A239V, R271G, R271Q, and V567I were newly identified in this study. Functional analyses of the mutations with luciferase reporter assay showed that all of the mutant proteins examined had decreased transactivation activities compared to wildtype. The R272H and P379fsdelCT mutations were previously identified in patients who had a severe form of diabetes with no detectable C-peptide, suggesting the presence of factors modifying severity of the disease (Fig. 1) . The R131W and R159Q mutations were identified in two and three unrelated patients, respectively, and codon 271 was affected in the four patients with R271G, R271Q, or R271W, suggesting that these sites could be a mutational hotspot. All of the patients with the mutations had a family history of diabetes, except for patients, Y26, Y35, and Y135. Of these, DNA samples of both parents and a brother of patient Y35, who had the R131W mutation, were available for gene testing. Direct sequencing of TCF1 in these family members showed no nucleotide alteration in the corresponding portion in either allele. Genotyping these subjects with 12 microsatellite markers confirmed paternity (combined plausibility 0.9995), indicating the occurrence of a de novo mutation in codon-131 in patient Y35. We then examined the relation between the HNF-1α mutations and BMI in all patients. We first compared BMIs of patients with and without the mutations. Those with the mutations were found to have a lower BMI at diagnosis (20.1±3.0 kg/m 2 ) than those without mutations (24.3±6.1 kg/m 2 ) (p=0.0024) ( Table 1) . All of the patients with the mutations in this study had normal body weight, except for one, Y120. The frequency of HNF-1α mutations in the non-obese patients was 17% (17/101). Patient Y120, who had R272H in TCF1, had atypical symptoms of mild obesity, hyperinsulinaemia, and insulin resistance at diagnosis. This patient had previously been found to have an R34X nonsense mutation in the small heterodimer partner (SHP) gene (NR0B2) [5] ; SHP is an atypical orphan nuclear receptor that suppresses transactivation activity of a number of nuclear receptors including HNF-4α (MODY1 protein). Functional defects of SHP are associated with mild obesity and insulin resistance in Japanese, although by a molecular mechanism that is not known. Patient Y120 was mildly obese or overweight (BMI 25.7 kg/m 2 ) at diagnosis. The body fat content of this patient was directly estimated by dual-energy X-ray absorptiometry to be 48.8%, 39.3%, and 41.0% in the upper extremities, trunk, and lower extremities, respectively (the control subjects at age 12-14 years in Japanese subjects; 7.5±2.3%, 9.4±4.3%, and 14.0±2.9%, respectively), indicating generalized fat distribution. Decreased insulin sensitivity also was determined at diagnosis by euglycaemic hyperinsulinaemic clamp method (glucose infusion rate, 4.7 mg·kg -1 ·min -1 ; control subjects, 7.8±0.2 mg·kg -1 ·min -1 ), and was consistent with the increased concentration of fasting plasma insulin (150 pmol/litre). Although many patients with HNF-1α mutations are highly sensitive to the hypoglycaemic effects of sulphonylureas [6] , the diabetic state of this subject was refractory to oral drug therapy and is being treated with insulin possibly due to the combined effects of the mutations. Analysis of other family members is necessary to understand the effects of gene interaction on the phenotype. However, DNA samples from parents and other family members were not available.
High frequency of HNF-1α mutations in young lean patients and identification of a case of double muta-
Discussion
We carried out a large-scale gene screening for HNF-1α mutations in Japanese patients with early-onset diabetes. Combined with our previous surveys in various age distributions (Table 2) , HNF-1α mutations are clearly found most frequently (17%) in lean patients with diabetes diagnosed before 15 years of age. Haplotype analysis of three Caucasian families of patients with the common mutation P291fsinsC [7] and the presence of a number of common mutations in different races suggested that the TCF1 locus is a mutational hotspot. The case of patient Y35, with the de novo mutation on a different site, is a direct evidence of this locus being a mutational hotspot. Because the early symptoms of MODY3 sometimes include rapid progress to dependence on insulin treatment [4] , it is important to identify early people who are affected to initiate prompt therapy. When nonobese Japanese youth, especially those of school age, are diagnosed with diabetes, the HNF-1α gene should be screened for mutations even if diabetes is absent in their family history. Non-obese 1 (103) 1.0% [10] These results are combined with our previous findings [4, 8, 9, 10] to show overall prevalence of the HNF-1α mutations in each age group. Of those diagnosed after 15 years, only nonobese subjects were examined previously. These findings apply only to the coding region of the HNF-1α gene. One obese patient diagnosed before 15 years of age has double mutations enes for HNF-1α and SHP [5] Over 80 different mutations in the HNF-1α gene associated with MODY have been described so far. However, the phenotypic features of the disease vary greatly among patients even in the same family, suggesting the presence of modifying genetic factors [4] . We have shown that mutations in the SHP gene are associated with mild obesity and insulin resistance in Japanese subjects [5] . Initially, these SHP mutations were found serendipitously in the obese proband of MODY families in which most of the other diabetic members were lean. Genotype analysis of the family members did not show linkage of the SHP mutations to early-onset diabetes, indicating the presence of both the SHP mutations and independent MODY mutations in the affected families. In this study, we found one patient with mutations in both the HNF-1α and the SHP genes. Since atypical MODY symptoms of obesity and insulin resistance were observed at diagnosis in this patient, the defect of SHP which is an upstream regulator of TCF1 in the regulatory cascade could be dominant over the HNF-1α mutation in the modification of the MODY3 phenotypes. However, the significance of this modification in the pathogenesis of diabetes is not known. Since all of the patients with the HNF-1α mutations except for the patient Y120 with double mutations are lean, lack of obesity seems to be a characteristic of the phenotype of MODY3. Alternatively, defects of unknown obesity-related genes that are not common in Japanese people could modify the MODY3 phenotype in Caucasian subjects. Accordingly, it is important to accumulate knowledge of such modifiers to clarify the epistatic gene interactions and the complex genotype-phenotype relations in diabetes.
